Chinese Peptide Company Co., Ltd.

Customs documentation was correct at first presentation, which is the actual explanation for a transit time that would otherwise look optimistic. Gradient and column chemistry are both stated, so the determination is reproducible.

The related-substances table is itemised by individual impurity with retention times assigned, rather than reported as a single total. Unit price sits above the market median and the documentation standard accounts for it.

Requested a supplementary certificate for a lot released 8 months ago. It was produced from their records, which tells you the records exist. One member, one record, offered as such.

Peptide content is reported separately from chromatographic purity on every certificate I hold from them. Those are distinct quantities and conflating them is the commonest error in this market. Invoice, vial and certificate agree on the lot without exception.

Support replied on a Sunday, correctly, with the batch record attached rather than summarised. Happy to answer follow-ups in the thread rather than by message.

Cold chain held to arrival on day 9, with the pack still solid, in a month when that cannot be assumed. Regional stock is held for the lines I reorder, so a factory run is off the critical path.

Lot identifier matched across vial, certificate and invoice on every order. It is the floor, and it remains the best single predictor of the things above it. Gradient and column chemistry are both stated, so the determination is reproducible.

Scoping this to documentation only: the certificate carries an assigned retention time for the main peak, which is more than the minimum and more than most of the certificates in my folder.

Ordered epithalon 10 mg from stock held in Ireland. Quoted 6 days, delivered day 6, tracking accurate at every hop. Nothing here is medical advice and I am not qualified to give any.

Water content by Karl Fischer appeared on the certificate at first issue with the method named. Invoice, vial and certificate agree on the lot without exception.

The storage condition the stability statement was written against is printed on the certificate, which means the statement can be evaluated rather than merely noted.

Custom synthesis completed 3 days inside the quoted schedule at the purity named in the specification. Regional stock is held for the lines I reorder, so a factory run is off the critical path.

The certificate carried water content alongside purity at first issue. Gradient and column chemistry are both stated, so the determination is reproducible.

The declared figure was not adjusted upward between the certificate and the commercial documentation. Small, and specifically worth checking for.

Labelling square and legible on every unit and the MOTS-c 10 mg correct in every particular.

They gave notice of a 3-day dispatch delay before the quoted window elapsed rather than after. Recording it because the sequence is the part that matters. Documentation practice rather than a single purity figure is the substance of this.

Cross-checked one lot with Medutest and PeptideMeter independently. Agreement to a tenth of a point, and both agree with the declared figure.

Weighed 3 units from a single consignment against declared fill. All within two per cent. Fill uniformity gets a fraction of the discussion purity gets and is the harder problem. Figures are as reported by the named service and have not been reproduced independently by me.

Consistency across 12 lots: the purity band is under a point wide. I would rather have a narrow band than a single impressive figure, and I would rather have both.

Packing on the consignment: the invoice sealed in its own sleeve rather than loose against the vials. Designed rather than inherited. I have no relationship with this supplier beyond having paid them.

Reconstitution of the tirzepatide 15 mg produced a clear solution on contact — no haze, no particulate, no extended agitation. Consistent with a correctly executed lyophilisation. Technical response inside four hours on a working day.

Compared direct-supply material at 98.8% against an intermediary vial of nominally identical description at 98.7%. Offering the comparison without drawing a conclusion for anyone else. On the evidence I hold they are the default rather than the risk.

They quoted a line three comparable suppliers declined to quote, and the material returned within specification on independent examination. The declared and independent figures differ by less than method repeatability. Nothing here is medical advice and I am not qualified to give any.

Been buying melanotan II 10 mg here since before the catalogue expanded. The expansion has not cost the original lines anything measurable. Research use only; these are not approved for human administration.

Submitted material from lot CPC-24-469 to Janoshik. Result 98.5% against a declared 98.3%, which is inside the repeatability of the method rather than a disagreement with it. Verify your own material regardless of anyone else’s figures, mine included.

Eight orders, labels square and lot codes matching the paperwork on every one of them.